ADITXT INC.

NASDAQ: ADTX (Aditxt, Inc.)

Last update: 3 hours ago

0.070

0.00 (-6.54%)

Previous Close 0.075
Open 0.068
Volume 107,125,440
Avg. Volume (3M) 30,103,596
Market Cap 5,522,489
Price / Earnings (TTM) 0.000
Price / Sales 0.020
Price / Book 1.53
52 Weeks Range
0.065 (-7%) — 218.00 (311328%)
Earnings Date 14 Apr 2025 - 18 Apr 2025
Operating Margin (TTM) -13,497.11%
Diluted EPS (TTM) 628.80
Quarterly Revenue Growth (YOY) -80.00%
Total Debt/Equity (MRQ) 126.76%
Current Ratio (MRQ) 0.070
Operating Cash Flow (TTM) -19.59 M
Levered Free Cash Flow (TTM) -13.26 M
Return on Assets (TTM) -117.61%
Return on Equity (TTM) -3,493.63%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Mixed
Biotechnology (Global) Mixed Mixed
Stock Aditxt, Inc. Mixed Mixed

AIStockmoo Score

0.0
Analyst Consensus NA
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 2.5
Technical Oscillators -0.5
Average 0.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ADTX 6 M - 0.000 1.53
CYTK 5 B - - 60.31
SRRK 4 B - - 42.81
REPL 1 B - - 2.25
GHRS 868 M - - 4.94
QURE 758 M - - 15.00

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 0.01%
% Held by Institutions 0.25%

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria